Results 121 to 130 of about 50,591 (247)

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 728-740, January 2026.
Abstract Aims This study aimed to evaluate the efficacy and safety of triple therapy with lobeglitazone 0.5 mg as an add‐on treatment compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin.
Da Hea Seo, Kyung Wan Min, Ho Sang Sohn, Sang Yong Kim, In‐Kyung Jeong, Cheol‐Young Park, Kun‐Ho Yoon, So Hun Kim, Bong‐Soo Cha   +8 more
wiley   +1 more source

Cystoid macular edema

Clinical Ophthalmology, 2008
Tryfon G Rotsos1, Marilita M Moschos21Medical Retina Service, Moorfields Eye Hospital, London, UK; 2Department of Ophthalmology, University of Athens, GreeceAbstract: We review the epidemiology, pathophysiology, and etiology of cystoid macular edema (CME)
Tryfon G Rotsos, Marilita M Moschos
doaj  

Prevalence of diabetic macular edema among type II diabetic patients in tele-screening program using OCT and fundus photos in a tertiary hospital, Riyadh, Saudi Arabia

International Journal of Retina and Vitreous
Purpose To provide local data on the prevalence and risk factors of diabetic macular edema in the Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Abdullrahman Mohammed Alshehri, Mohammed Naji Almutairi, Mishari Alqahtani, Abdullmajeed Alfakhri   +3 more
doaj   +1 more source

Combined therapy in diabetic macular edema [PDF]

, 2015
Purpose: To determine the effectiveness of three different combinations for the ‘‘loading phase’’ in the treatment of diabetic macular edema (DME), using bevacizumab (BVZ), triamcinolone (TCL) and subthreshold macular photocoagulation (SMPC).
Butrón Valdez, K., González Cortés, Jesús Hernán, Guerra Leal, Jesús Dante, Martínez Gamero, Bertha Olivia, Mohamed Hamsho, Jesús, Toledo Negrete, Juan José, Treviño Cavazos, Ezequiel Enrique, Zapata Elizondo, V.   +7 more
core  

Anti-vascular endothelial growth factor drugs combined with laser photocoagulation maintain retinal ganglion cell integrity in patients with diabetic macular edema: study protocol for a prospective, non-randomized, controlled clinical trial

, 2023
Xiangjun Li, Chunyan Li, Hai Huang, Dan Bai, Jingyi Wang, Angela Chen, Yu Gong, Y Leng   +7 more
openalex   +1 more source

Safety and Efficacy of Vadadustat Versus Darbepoetin Alfa for Chronic Kidney Disease–Related Anemia in Patients Receiving Dialysis by Baseline Erythropoiesis‐Stimulating Agent Dose

Hemodialysis International, Volume 30, Issue 1, Page 80-100, January 2026.
ABSTRACT Introduction Erythropoiesis‐stimulating agents (ESAs) and iron supplementation are standard treatments for chronic kidney disease (CKD)–related anemia. Targeting higher hemoglobin values in CKD increases cardiovascular risk. Whether the increased risk is from higher ESA doses or higher hemoglobin levels is uncertain, but alternative therapies ...
Alan Jardine, Steven K. Burke, Wenli Luo, Todd Minga, Mark J. Sarnak, Wolfgang C. Winkelmayer, Rajiv Agarwal, Glenn M. Chertow, Kai‐Uwe Eckardt, Mark J. Koury   +9 more
wiley   +1 more source

Visual function and retinal morphological changes after single suprachoroidal delivery of fluocinolone acetonide (Iluvien®) implant in eyes with chronic diabetic macular edema [PDF]

, 2023
Ehab N. El Rayes, M. Leila
openalex   +1 more source

Extracellular Vesicle‐Derived microRNAs as Fluid Biomarkers in Neurodegenerative Diseases: A Systematic Review

Journal of Neurochemistry, Volume 170, Issue 1, January 2026.
Given the absence of curative treatments for neurodegenerative diseases, early detection and therapeutic intervention are critical to slowing disease progression. The last decade has seen accumulating evidence for microRNA dysregulation in circulating extracellular vesicles (EVs); however, assessing reproducibility between studies remains challenging ...
Aliyah Zaman, Sienna S. Drake, Alyson E. Fournier   +2 more
wiley   +1 more source

Role of Systemic Factors in the Progression to Vision‐Threatening Diabetic Retinopathy in a New Mexican Patient Population with Type 2 Diabetes: Glycemic Control Is Not Enough

Journal of Diabetes Research, Volume 2026, Issue 1, 2026.
Purpose The purpose of this study is to identify associative factors of vision threatening complications of diabetic retinopathy (DR), including proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME) in a New Mexican patient population with Type 2 diabetes featuring a high proportion of Hispanic and American Indian patients.
Rushi N. Mankad, Lauren Marek, Gabriella Acosta, Andrea P. Cabrera, Finny Monickaraj, Clifford Qualls, Arup Das, Riccardo Calafiore   +7 more
wiley   +1 more source

Triamcinolona subtenoniana en el edema macular diabético Subtenon triamcinolone in the diabetic macular edema

Revista Cubana de Oftalmología, 2009
INTRODUCCIÓN: La prevalencia de la retinopatía diabética está determinada por el tipo de diabetes mellitus y por el tiempo de evolución de la enfermedad.
Eddy Mesa Hernández, Odalis González Peña, Isabel Medina Rodríguez, Rafael González Díaz, Emoe Pérez Muñoz   +4 more
doaj